Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | MMP3 | P08254 | 3/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | MYB | P10242 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | PDE9A | O76083 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20405158 | 0.81 | SLC22A12 (0.50) | SLC22A12CA1CA2MMP3PDPK1 | |
| SCHEMBL19435502 | 0.79 | SLC22A12 (0.51) | SLC22A12CA1CA2MMP3MEN1 | |
| SCHEMBL19435544 | 0.79 | SLC22A12 (0.48) | SLC22A12CA1CA2MMP3PDPK1 | |
| SCHEMBL31543984 | 0.79 | ALDH1A1 (0.46) | TSHR | |
| SCHEMBL18320175 | 0.79 | ALDH1A1 (0.46) | TSHR | |
| SCHEMBL23624465 | 0.78 | CA1 (0.53) | SLC22A12CA1CA2MMP3PDPK1 | |
| SCHEMBL26315772 | 0.77 | CA1 (0.46) | SLC22A12CA1CA2MMP3PDPK1 | |
| SCHEMBL13191989 | 0.77 | MMP3 (0.52) | SLC22A12CA1CA2MMP3CA12 | |
| SCHEMBL22508423 | 0.76 | PDPK1 (0.45) | SLC22A12CA1CA2MMP3PDPK1 | |
| SCHEMBL29521590 | 0.76 | PDPK1 (0.45) | SLC22A12CA1CA2MMP3PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737358-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-11737358-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| WO-2019182402-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737358-B2 | Compound and organic light emitting device comprising same | ARNT, CYP1A1, AHR | SLC22A12 3035/4885CA1 3935/4885CA2 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.